Latitude Food Allergy Care

What Latitude Food Allergy Care does

Latitude Food Allergy Care (legal entity forTRA Health Inc.) is a private, physician-led specialty clinic network that diagnoses and treats food allergies in pediatric and adult patients, with a clinical focus on Oral Immunotherapy (OIT) to desensitize patients to specific allergens. Operating under founder/CEO Kimberley Yates since 2017, the practice has grown to 13 clinic locations spanning the San Francisco Bay Area, Southern California, and New York, staffed by 51–100 employees. Core services include four-step diagnostic testing (skin prick, blood/IgE, component testing, oral food challenges), OIT protocols built on studies from Stanford, Duke, and Baylor, adjunct biologic therapy with Xolair (omalizumab, FDA-approved for food allergy reduction in February 2024), Palforzia for peanut allergy, early-introduction prevention programs, and long-term maintenance dosing. Reported internal outcomes include 92% desensitization across all ages and 97% for patients under 4.

The business model is primarily fee-for-service clinical revenue billed through insurance, supplemented by recurring revenue from biweekly updose appointments and multi-year maintenance dosing. Distribution is direct-to-patient across physical clinic locations, with demand driven by physician referrals, self-referrals, and clinical partnerships with UCSF Benioff Children's Physicians, Weill Cornell Medicine, and the Children's Hospital Los Angeles Care Network. The practice accepts most insurance plans and integrates with UCSF Health MyChart (Northern California) and AdvancedMD (New York and Southern California) patient portals.

Strategically, Latitude competes on clinical specialization (allergists 100% focused on food allergy), academic affiliations, geographic convenience relative to documented 12-month wait times at traditional allergists, and published outcomes data. Most recently, the company opened a fifth Southern California clinic in Poway (San Diego) in June 2026, continuing a clinic-by-clinic expansion strategy. The company has raised approximately $24.6M cumulatively across funding rounds in 2018 and 2019, and remains founder-led with no disclosed institutional control.

Name

Latitude Food Allergy Care

Legal name

forTRA Health Inc.

Website

https://latitudefoodallergycare.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

Latitude Food Allergy Care is a physician-led specialty clinic network operating 13 locations in California and New York, providing oral immunotherapy, Xolair, diagnostic testing, and prevention services to children and adults with food allergies, billed primarily through insurance.

Ownership category

akta.pro rank

Product category

Allergy Treatment Services

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Food Allergy Evaluation & Management (HLAKAAAD)

akta.pro secondary industries

Allergy & Immunology Clinics (HLAKAAAA), Pediatric Allergy & Immunology (HLAKAAAB)

Keywords

• Food allergy treatment
• Oral immunotherapy
• Pediatric allergy care
• Allergy diagnostic testing
• Specialty allergy clinic

Headquarters

HQ city

Redwood City

HQ country

United States

HQ region

North America

Offices12 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Clinical Services Revenue: Revenue generated from physician consultations, diagnostic testing (skin prick, blood tests, oral food challenges), and ongoing treatment visits. Billed to insurance or patients directly.
2. Oral Immunotherapy Treatment: Recurring revenue from OIT treatment protocols including updose appointments every two weeks and ongoing maintenance visits throughout the desensitization process.
3. Xolair Administration: Revenue from Xolair (omalizumab) injections, which are covered by most insurance plans for approved indications including the February 2024 FDA approval for food allergy reduction.
4. Insurance Reimbursement: The practice is in-network with most insurance carriers and accepts insurance for services. This includes UCSF Health patient portal integration for Northern CA patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Latitude Food Allergy Care operates physician-led specialty clinics that diagnose food allergies through a four-step testing process (skin prick, IgE blood, component, and oral food challenges) and treat them primarily with oral immunotherapy (OIT) — gradually exposing patients to increasing doses of their allergens to achieve desensitization. Treatment is often combined with Xolair (omalizumab) or Palforzia for enhanced safety or for specific allergens, and is supported by a proprietary mobile app for dose tracking. The company serves pediatric and adult patients across 11 clinic locations in California and New York.

Product overview

Latitude Food Allergy Care is a physician-led healthcare network offering comprehensive food allergy care across California and New York. The core service portfolio centers on Food Allergy Testing (skin prick, blood, component, and oral food challenges) and Oral Immunotherapy (OIT) treatment, which can be enhanced with Xolair or Palforzia. Additional services include Prevention programs based on early allergen introduction protocols, Long Term Care for maintenance phase patients, and EpiPen education. The company operates multiple clinic locations with affiliated relationships to UCSF Benioff Children's Physicians and Children's Hospital Los Angeles (CHLA).

Differentiator

Problem solved

Functional benefit

Products and services

• Food Allergy Testing Comprehensive diagnostic services including skin prick testing, blood tests measuring IgE antibodies, component testing to assess tolerance to specific allergen components, and oral food challenges to definitively determine food allergies. For pediatric and adult patients suspected of food allergies.
• Oral Immunotherapy (OIT) Evidence-based food allergy treatment that desensitizes patients by gradually exposing them to increasing amounts of their allergens, retraining the immune system to reduce adverse reactions and protect against severe reactions from accidental exposures. Biweekly updose visits over a multi-month protocol. For pediatric and adult patients with diagnosed food allergies.
• Xolair (Omalizumab) Therapy Anti-IgE monoclonal antibody (Genentech/Novartis) administered in conjunction with oral immunotherapy to inhibit allergic reactions and increase safety for patients who require additional protection during desensitization. Covered by most insurance plans for approved indications. For food-allergic patients undergoing OIT who need enhanced safety.
• Palforzia Peanut Allergy Treatment FDA-approved oral immunotherapy drug specifically indicated for peanut allergy treatment. Protocol begins with a small initial dose mixed with food followed by a series of updoses, typically with every-two-week updose visits over ~6 months. For children ages 4 through 17 with peanut allergy.
• Food Allergy Prevention Early introduction programs and preventive care for infants, particularly those with eczema or a family history of food allergies. Based on 2017 NIAID guidelines for early peanut introduction. For parents of at-risk infants seeking to prevent food allergy development.
• Long Term Care Ongoing maintenance and monitoring for patients who have completed initial OIT treatment phases, including continued support for OIT maintenance dosing and regular follow-up care to sustain desensitization. For patients who have completed initial OIT updosing.
• EpiPen Education and Management

Quantifiable outcome

• 97% of patients under 4 years achieved desensitization with OIT (internal data, 2024)
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Children's Hospital Los Angeles (CHLA)coreStrategic or Co-development PartnerLatitude Food Allergy Care is affiliated with Children's Hospital Los Angeles as a Member of Care Network. This affiliation provides clinical credibility, referral pathways, and institutional backing for the food allergy treatment network.
• UCSF / UCSF Benioff Children's PhysicianscoreStrategic or Co-development PartnerClinical partnership with UCSF ensuring continued provision of specialized food allergy care. Northern CA patients access UCSF Health MyChart patient portal through Latitude. The partnership contributes to research and clinical excellence.
• Weill Cornell MedicinecoreStrategic or Co-development PartnerClinical partnership with Weill-Cornell for ongoing research collaboration. Latitude has published OIT data with Weill Cornell, demonstrating commitment to clinical research and evidence-based treatment protocols.
• Food Allergy Research & Education (FARE)minorOthersFARE logo appears on the Latitude website indicating partnership with the leading food allergy research and advocacy organization. Latitude references FARE resources and emergency care plans.
• Stanford, Duke, and Baylor Research InstitutionsminorStrategic or Co-development PartnerLatitude's evidence-based OIT program is built on clinical studies and protocols from Stanford, Duke, and Baylor, indicating use of established research frameworks in developing treatment protocols.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Allergy Partners: Largest U.S. network of board-certified allergist practices, operating de novo and affiliated clinics across multiple states. Most direct comparable to Latitude in being a multi-site private allergy practice, although Allergy Partners is broader (asthma, allergy, immunology) rather than food-allergy-only.
• Atlanta Allergy & Asthma: Large private multi-location allergy and asthma practice in the Southeast. Directly comparable as a physician-owned specialty group delivering recurring, insurance-billed allergy care, though with a broader therapeutic scope than Latitude's food-allergy focus.

Others

• Allergy & Asthma Network: National nonprofit patient advocacy and education organization for allergy, asthma, and related conditions. Comparable as an ecosystem player in the food-allergy patient community that Latitude engages with, and a natural partnership channel for awareness campaigns.
• Aimmune Therapeutics (Nestlé Health Science): Developer and commercializer of Palforzia, the FDA-approved oral immunotherapy for peanut allergy, now part of Nestlé Health Science. An ecosystem participant and supplier-adjacent to Latitude, which administers Palforzia in its clinics.
• Sean N. Parker Center for Allergy & Asthma Research at Stanford: Stanford-based academic research and clinical program pioneering OIT protocols. Comparable in clinical approach and patient population; competes for tertiary referrals in Northern California but as a research institution rather than a private clinic network.
• Jaffe Food Allergy Institute (Mount Sinai): Leading academic food allergy treatment and research program in New York. Comparable in therapeutic approach (OIT, food challenges) and patient base; overlaps with Latitude's New York clinics for tertiary food-allergy referrals.
• Food Allergy Research & Education (FARE): Largest U.S. nonprofit dedicated to food allergy research, advocacy, and education. A partner and ecosystem enabler for Latitude, with shared patient-community reach and co-branded awareness initiatives.
• Texas Children's Hospital Food Allergy Program: Major academic pediatric food allergy program in Houston. Comparable in pediatric OIT clinical capabilities and outcomes research; competes for complex referrals but is anchored in a single academic system rather than a multi-state private clinic network.
• Schweiger Dermatology Group: PE-backed multi-site dermatology specialty practice network. Comparable as a rollup business model in physician-led specialty care with insurance reimbursement, useful as a business-model (not clinical) peer for a PE analysis of Latitude.
• US Anesthesia Partners: Multi-site, PE-backed specialty medical group. Comparable as a business-model peer showing how specialty physician groups scale through de novo growth and acquisitions while operating in a recurring, insurance-reimbursed revenue model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/groups/2092065717762698

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Latitude Food Allergy Care